Amrn | PennyStockPayCheck.com

Featured Posts

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Eurozone crisis live: Japan's strong growth figures... PM Shinzo Abe's stimulus package could generate feelgood factor needed to end two decades of stagnant growthPhillip Inman

Amarin Prescription Fish-Oil Pill Approved

Posted by admin | Posted on 27-07-2012

Category : Stocks

Tags: amarin, amrn, approved, fatty, fda, health care, price, quote

Updated with new information.

BEDMINSTER, NJ (TheStreet) –The U.S. Food and Drug Administration on Thursday approved a prescription fish-oil pill from Amarin that will be used to treat patients with very high levels of triglycerides, a type of fat found in blood.

Amarin’s newly approved drug Vascepa is made from ultra-purified ethyl EPA, an omega-3 fatty acid commonly found in fish. An FDA spokesperson confirmed the approval. …

Click to view a price quote on AMRN.

Click to research the Drugs industry.